U.S. FDA Grants 510(k) Expanded Indication for Palliare’s EVA15 Insufflation Technology to Accommodate Higher Pressure Range
31 janv. 2023 09h00 HE
|
Palliare
Oceanside, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Palliare, a leading developer of advanced insufflation technologies, has received an expanded 510(k) indication from the U.S. Food and Drug...